What is Vericel's long-term marketable securities?

Vericel (VCEL) reported long-term marketable securities of $65.28M in Q1 2026.

How has Vericel's long-term marketable securities changed year-over-year?

Vericel's long-term marketable securities increased by 50.6% year-over-year, from $43.34M to $65.28M.

What is the long-term trend for Vericel's long-term marketable securities?

Over 5 years (2020 to 2025), Vericel's long-term marketable securities has grown at a 20.6% compound annual growth rate (CAGR), from $24.1M to $61.4M.

Vericel VCEL Long-term marketable securities

Long-term marketable securities at other companies

Globus MedicalGMED

——

Other financials

Income statement

See full

Revenue$68.4M+30.1%

Gross profit$49.3M+35.8%

Operating income-$8.1M+37.0%

Net income-$6.3M+44.0%

EPS (diluted)-$0.12+47.8%

Balance sheet

See full

Cash & equivalents$109.3M+37.1%

Total debt$95.0M-4.6%

Total equity$356.2M+20.6%

Total assets$485.6M+14.4%

Cash flow

See full

Operating cash flow$16.4M+148%

CapEx$1.3M-91.2%

Free cash flow$15.1M+299%

Valuation

See full

Market cap$2.13B-26.8%

Enterprise value$2.11B-28.0%

P/E99.2×-877×

P/S7.3×-4.9×

Profitability

See full

Gross margin74.8%+2.3pp

Operating margin5.4%+4.6pp

Net margin7.3%+6.1pp

FCF margin16.3%—

Returns & leverage

See full

Return on equity6.6%+5.5pp

Debt / equity0.3×-0.1×

Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's long-term marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vericel's long-term marketable securities?: Vericel (VCEL) reported long-term marketable securities of $65.28M in Q1 2026.
How has Vericel's long-term marketable securities changed year-over-year?: Vericel's long-term marketable securities increased by 50.6% year-over-year, from $43.34M to $65.28M.
What is the long-term trend for Vericel's long-term marketable securities?: Over 5 years (2020 to 2025), Vericel's long-term marketable securities has grown at a 20.6% compound annual growth rate (CAGR), from $24.1M to $61.4M.